What is the main business of Selprima?

The main business activity of Selprima focuses on non-specialised wholesale trade.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 13, 2011.

Where is the headquarters located?

The headquarters is located at: Kazachska 1, 02-999 Warszawa.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $81,984, representing a decrease of 85.5% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $10,090, meaning the company decreased its profit by 28.0%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $22,248 in 2025, representing 33% of all operating expenses.

Selprimasp. z o.o.

Non-specialised wholesale trade

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-09-13

Share capital

50,000.00 PLN

Average employment (people)

1 (2025)

Activity description

Selprima Sp. z o.o. is a Polish company trading in lecithin, feed components and vegetable oils. It specializes in importing liquid sunflower lecithin for food and technical use and sells sunflower-derived, non-GMO raw materials.

Registered address

Kazachska 1/20, 02-999 Warszawa, Poland

Website

selprima.eu

Phone

Electronic delivery address

AE:PL-95505-39359-UEHVW-23

Financials

Revenue history (in k)

From the notes

Profit allocation

Loss to be covered

Filing timeliness

Financial statements were filed on time, on average 108 days early. 1 of 6 audited by a statutory auditor.

202530/03/2026
202429/03/2025
202328/03/2024
202230/03/2023
202128/06/2022
202031/03/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 81.98kMedianUSD 635.22kAverageUSD 7.52m

Net profit

This companyUSD 10.09kMedianUSD 12.57kAverageUSD 217.45k

Operating costs

This companyUSD 66.90kMedianUSD 586.83kAverageUSD 7.20m

Assets

This companyUSD 354.05kMedianUSD 367.33kAverageUSD 3.43m

Industry

Authorized Representatives

Michał Bogdan Zahn – Attorney-in-fact (sole)

Jarosław Marciniak – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Barbara Zahnage 71	200	$5,402.49	40%
Michał Bogdan Zahnage 43	300	$8,103.73	60%

Michał Bogdan Zahn and Barbara Zahn hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2011-10-12.

mBank
32 1140 1010 0000 5379 2600 1001
mBank
70 1140 2017 0000 4402 1286 4887
mBank
05 1140 1010 0000 5379 2600 1002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Lompartsp. z o.o.	$231,854.52	lompart.pl
Powsenasp. z o.o.	$150,531.55	powsena.pl
NutrisleP.S.A.	$135,614.44	nutrisle.com
Agroimpulsesp. z o.o.	$119,156.41	agroimpulse.eu
Chemya Polskasp. z o.o.	$119,051.62	chemya.pl
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com
Medisolutionsp. z o.o.	$72,164.42	medisolution.pl
Libellasp. z o.o.	$69,675.40	libella.com.pl
Leenlife PharmaS.A.	$47,609.40	leenlife.com
Skynerasp. z o.o.	$35,079.61	skynera.pl

Change history

Date	Event
2015-07-27	PKD change (Removed: 46 codes; Added: 2 codes)
2012-12-13	Address change (Roentgena 23/21, 02-781, Warszawa → Kazachska 1/20, 02-999, Warszawa)
2011-09-13	Entered in the register

FAQ

Last updated: 2026-07-28